| Dr Richard T Leach, DO | |
|
5555 Post Rd, East Greenwich, RI 02818-3412 | |
| (401) 884-2229 | |
| (401) 884-0850 |
| Full Name | Dr Richard T Leach |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 5555 Post Rd, East Greenwich, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407852155 | NPI | - | NPPES |
| 9003058 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | DO00374 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Warwick, RI | Home health agency |
| Vna Of Care New England | Warwick, RI | Home health agency |
| Vna Of Care New England | Warwick, RI | Hospice |
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Women & Infants Hospital Of Rhode Island | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Physicians Llc. | 0244413391 | 619 |
News Archive
The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.
Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
› Verified 6 days ago
| Entity Name | The Medical Group Of Rhode Island, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033193925 PECOS PAC ID: 4981620945 Enrollment ID: O20051019000178 |
News Archive
The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.
Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
› Verified 6 days ago
| Entity Name | Affinity Physicians Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.
Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
› Verified 6 days ago
| Entity Name | Greenwich Bay Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912458068 PECOS PAC ID: 2062784465 Enrollment ID: O20170821000174 |
News Archive
The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.
Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard T Leach, DO 1050 Warwick Ave, Warwick, RI 02888-3655 Ph: (401) 467-6257 | Dr Richard T Leach, DO 5555 Post Rd, East Greenwich, RI 02818-3412 Ph: (401) 884-2229 |
News Archive
The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.
Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
› Verified 6 days ago
Dr. William M Corrao, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1285 S County Trl, East Greenwich, RI 02818 Phone: 401-886-7910 Fax: 401-886-7913 | |
Denise F Glickman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1672 S County Trl, Suite 303, East Greenwich, RI 02818 Phone: 401-884-0020 Fax: 401-884-0019 | |
Kristen Hubbard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1598 S County Trl Ste 201, East Greenwich, RI 02818 Phone: 401-884-0333 Fax: 401-884-0096 | |
Mr. Brian G Abbott, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1377 S County Trl, East Greenwich, RI 02818 Phone: 401-886-7590 Fax: 401-886-7571 | |
Philip M. Trupiano, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1351 S County Trl, Building 2 Suite 220, East Greenwich, RI 02818 Phone: 401-884-4040 Fax: 401-884-4010 | |
Dr. David J Broza, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3461 S County Trl, East Greenwich, RI 02818 Phone: 401-471-6440 Fax: 401-889-5082 | |
Dr. Shahid A Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1351 S County Trl, Suite 215, East Greenwich, RI 02818 Phone: 401-886-9700 Fax: 401-884-4235 |